These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Classification and Antigen Molecules of Autoimmune Bullous Diseases. Hashimoto T; Qian H; Ishii N; Nakama T; Tateishi C; Tsuruta D; Li X Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189450 [TBL] [Abstract][Full Text] [Related]
13. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari. Atzori L; Deidda S; Aste N G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046 [TBL] [Abstract][Full Text] [Related]
14. An Oral Disease Severity Score validated for use in oral pemphigus vulgaris. Ormond M; McParland H; Donaldson ANA; Andiappan M; Cook RJ; Escudier M; Hullah E; Higham J; McMillan R; Taylor J; Shirlaw PJ; Challacombe SJ; Setterfield JF Br J Dermatol; 2018 Oct; 179(4):872-881. PubMed ID: 29297927 [TBL] [Abstract][Full Text] [Related]
15. Development of an Excel® spreadsheet to document disease activity in autoimmune bullous disease. Sebaratnam DF; Venugopa SS; Murrell DF Acta Dermatovenerol Croat; 2013; 21(3):207-8. PubMed ID: 24183229 [No Abstract] [Full Text] [Related]
16. Validation of an Oral Disease Severity Score (ODSS) tool for use in oral mucous membrane pemphigoid. Ormond M; McParland H; Thakrar P; Donaldson ANA; Andiappan M; Cook RJ; Escudier ME; Higham J; Hullah E; McMillan R; Taylor J; Shirlaw PJ; Challacombe SJ; Setterfield JF Br J Dermatol; 2020 Jul; 183(1):78-85. PubMed ID: 31571192 [TBL] [Abstract][Full Text] [Related]
17. Large International Validation of ABSIS and PDAI Pemphigus Severity Scores. Hébert V; Boulard C; Houivet E; Duvert Lehembre S; Borradori L; Della Torre R; Feliciani C; Fania L; Zambruno G; Camaioni DB; Didona B; Marinovic B; Schmidt E; Schumacher N; Hünefeld C; Schanz S; Kern JS; Hofmann S; Bouyeure AC; Picard-Dahan C; Prost-Squarcioni C; Caux F; Alexandre M; Ingen-Housz-Oro S; Bagot M; Tancrede-Bohin E; Bouaziz JD; Franck N; Vabres P; Labeille B; Richard MA; Delaporte E; Dupuy A; D'Incan M; Quereux G; Skowro F; Paul C; Livideanu CB; Beylot-Barry M; Doutre MS; Avenel-Audran M; Bedane C; Bernard P; Machet L; Maillard H; Jullien D; Debarbieux S; Sassolas B; Misery L; Abasq C; Dereure O; Lagoutte P; Ferranti V; Werth VP; Murrell DF; Hertl M; Benichou J; Joly P; ; J Invest Dermatol; 2019 Jan; 139(1):31-37. PubMed ID: 30301637 [TBL] [Abstract][Full Text] [Related]
18. Review of autoimmune blistering diseases: the Pemphigoid diseases. Daniel BS; Murrell DF J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1685-1694. PubMed ID: 31087464 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of Ear, Nose, and Throat Involvement in Pemphigus Vulgaris in Comparison with Pemphigus Severity Scoring Systems: A Cross-sectional Study. Bilgic-Teme A; Cem Temel I; Bostancı-Toptas A; Turhan M; Bozkurt S; Uzun S Acta Dermatovenerol Croat; 2018 Dec; 26(4):283-288. PubMed ID: 30665476 [TBL] [Abstract][Full Text] [Related]
20. Clinical significance of anti-desmoglein-1 and -3 circulating autoantibodies in Pemphigus Patients Measured by Area Index and Intensity Score. Patsatsi A; Kyriakou A; Giannakou A; Pavlitou-Tsiontsi A; Lambropoulos A; Sotiriadis D Acta Derm Venereol; 2014 Mar; 94(2):203-6. PubMed ID: 23995461 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]